Literature DB >> 14560363

Pathological basis of gastroesophageal reflux disease.

Parakrama Chandrasoma1.   

Abstract

Many of the present definitions of Barrett's esophagus are based on the dogma that 2 to 3 cm of cardiac mucosa normally line the distal esophagus and proximal stomach. Recent autopsy data refute this dogma. Cardiac mucosa has been shown to be frequently absent from the squamocolumnar junctional zone. When present, its extent is less than 0.5 cm in almost all children and most adults. Cardiac mucosal length increases with age. Patients who have cardiac mucosa are significantly more likely to have abnormal acid exposure in the esophagus as measured by 24-hour pH studies. The length of the cardiac mucosa correlates significantly with the amount of reflux: the greater the length of the cardiac mucosa, the more reflux there is. These new data provide insights into the pathology of gastroesophageal reflux. Normalcy is defined as an esophagus lined by squamous epithelium and a stomach lined by gastric mucosa. Reflux disease is defined by the presence of cardiac mucosa in a junctional biopsy. The severity of reflux disease is quantifiable by the length of cardiac mucosa present. Mutational reflux disease (Barrett's esophagus) is defined by the occurrence of intestinal metaplasia in cardiac mucosa and is quantitated by the amount of intestinal metaplasia present. Neoplastic reflux disease is defined as the occurrence of low grade dysplasia, high grade dysplasia, and adenocarcinoma in Barrett's esophagus. An attempt is made here to develop a rational grading system for reflux based on these highly objective histologic criteria.

Entities:  

Mesh:

Year:  2003        PMID: 14560363     DOI: 10.1007/s00268-003-7049-x

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  13 in total

1.  The lower end of the oesophagus.

Authors:  J HAYWARD
Journal:  Thorax       Date:  1961-03       Impact factor: 9.139

2.  Histology of the gastroesophageal junction: an autopsy study.

Authors:  P T Chandrasoma; R Der; Y Ma; P Dalton; M Taira
Journal:  Am J Surg Pathol       Date:  2000-03       Impact factor: 6.394

3.  Definition of histopathologic changes in gastroesophageal reflux disease.

Authors:  P T Chandrasoma; D M Lokuhetty; T R Demeester; C G Bremmer; J H Peters; S Oberg; S Groshen
Journal:  Am J Surg Pathol       Date:  2000-03       Impact factor: 6.394

4.  Inflammation and specialized intestinal metaplasia of cardiac mucosa is a manifestation of gastroesophageal reflux disease.

Authors:  S Oberg; J H Peters; T R DeMeester; P Chandrasoma; J A Hagen; A P Ireland; M P Ritter; R J Mason; P Crookes; C G Bremner
Journal:  Ann Surg       Date:  1997-10       Impact factor: 12.969

5.  Mucin histochemistry of the developing gastroesophageal junction.

Authors:  E Ellison; E Hassall; J E Dimmick
Journal:  Pediatr Pathol Lab Med       Date:  1996 Mar-Apr

6.  Carditis: a manifestation of gastroesophageal reflux disease.

Authors:  R Der; D D Tsao-Wei; T Demeester; J Peters; S Groshen; R V Lord; P Chandrasoma
Journal:  Am J Surg Pathol       Date:  2001-02       Impact factor: 6.394

7.  Does duodenal juice reflux into the esophagus of patients with complicated GERD? Evaluation of a fiberoptic sensor for bilirubin.

Authors:  W K Kauer; P Burdiles; A P Ireland; G W Clark; J H Peters; C G Bremner; T R DeMeester
Journal:  Am J Surg       Date:  1995-01       Impact factor: 2.565

8.  Ambulatory 24-h esophageal pH monitoring: normal values, optimal thresholds, specificity, sensitivity, and reproducibility.

Authors:  J R Jamieson; H J Stein; T R DeMeester; L Bonavina; W Schwizer; R A Hinder; M Albertucci
Journal:  Am J Gastroenterol       Date:  1992-09       Impact factor: 10.864

9.  Histologic classification of patients based on mapping biopsies of the gastroesophageal junction.

Authors:  Parakrama T Chandrasoma; Roger Der; Yanling Ma; Jeffrey Peters; Tom Demeester
Journal:  Am J Surg Pathol       Date:  2003-07       Impact factor: 6.394

10.  Rising incidence of adenocarcinoma of the esophagus and gastric cardia.

Authors:  W J Blot; S S Devesa; R W Kneller; J F Fraumeni
Journal:  JAMA       Date:  1991-03-13       Impact factor: 56.272

View more
  3 in total

1.  Reflux, Barrett's, and adenocarcinoma of the esophagus: can we disrupt the pathway?

Authors:  Steven R DeMeester
Journal:  J Gastrointest Surg       Date:  2010-01-22       Impact factor: 3.452

2.  Kyoto international consensus report on anatomy, pathophysiology and clinical significance of the gastro-oesophageal junction.

Authors:  Kentaro Sugano; Stuart Jon Spechler; Emad M El-Omar; Kenneth E L McColl; Kaiyo Takubo; Takuji Gotoda; Mitsuhiro Fujishiro; Katsunori Iijima; Haruhiro Inoue; Takashi Kawai; Yoshikazu Kinoshita; Hiroto Miwa; Ken-Ichi Mukaisho; Kazunari Murakami; Yasuyuki Seto; Hisao Tajiri; Shobna Bhatia; Myung-Gyu Choi; Rebecca C Fitzgerald; Kwong Ming Fock; Khean-Lee Goh; Khek Yu Ho; Varocha Mahachai; Maria O'Donovan; Robert Odze; Richard Peek; Massimo Rugge; Prateek Sharma; Jose D Sollano; Michael Vieth; Justin Wu; Ming-Shiang Wu; Duowu Zou; Michio Kaminishi; Peter Malfertheiner
Journal:  Gut       Date:  2022-06-20       Impact factor: 31.793

3.  The columnar-lined mucosa at the gastroesophageal junction in non-human primates.

Authors:  Carlos A Rubio; Edward J Dick; Natalia E Schlabritz-Loutsevitch; Abiel Orrego; Gene B Hubbard
Journal:  Int J Clin Exp Pathol       Date:  2008-01-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.